CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Acquisition or sale completed · Delisting notice · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- CERTNAS Other Certification by the Nasdaq Stock Market
- 25 Other Notification of Removal from Listing
- 8-A12B Other Registration of Securities
- 10-Q Report Quarterly Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 424B3 Offering Prospectus
Page 35 of 74 · 1,467 filings